These data underline how the clinical severity of the disease, the number of vaso-occlusive crises and chronic hemolysis could adversely affect GH-IGF-1-IGFBP-3 axis in SCD patients. This evidence concerns the gene IGF1 and Schnyder corneal dystrophy.